PEARSALLS LIMITED
Get an alert when PEARSALLS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-30 (in 7mo)
Last made up 2025-12-16
Watchouts
None on the register
Cash
£6M
+140.8% vs 2023
Net assets
£400M
+446.7% vs 2023
Employees
201
+28.8% vs 2023
Profit before tax
£50M
+243.5% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £38,858,000 | £41,667,000 | |
| Operating profit | £18,028,000 | £18,822,000 | |
| Profit before tax | £14,435,000 | £49,580,000 | |
| Net profit | £11,198,000 | £45,908,000 | |
| Cash | £2,630,000 | £6,333,000 | |
| Total assets less current liabilities | £360,432,000 | £687,035,000 | |
| Net assets | £73,120,000 | £399,756,000 | |
| Equity | £73,120,000 | £399,756,000 | |
| Average employees | 156 | 201 | |
| Wages | £5,723,000 | £6,419,000 | |
| Directors' remuneration | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+7.2%
£38,858,000 £41,667,000
-
Cash
+140.8%
£2,630,000 £6,333,000
-
Net assets
+446.7%
£73,120,000 £399,756,000
-
Employees
+28.8%
156 201
-
Operating profit
+4.4%
£18,028,000 £18,822,000
-
Profit before tax
+243.5%
£14,435,000 £49,580,000
-
Wages
+12.2%
£5,723,000 £6,419,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 46.4% | 45.2% | |
| Net margin | 28.8% | 110.2% | |
| Return on capital employed | 5.0% | 2.7% | |
| Current ratio | 1.00x | 9.79x | |
| Interest cover | 0.52x | 0.61x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- PEARSALLS LIMITED 2000-01-14 → present
- QUAYSHELFCO 733 LIMITED 1999-09-30 → 2000-01-14
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”
Group structure
- PEARSALLS LIMITED · parent
- Corza Treasury 1 100%
- Corza Treasury 2 100%
- Corza Treasury 3 100%
- Corza Treasury 4 100%
- Pearsalls IP Limited 100%
- Corza Medical S.A.S. 100%
- Corza Medical GmbH 100%
- Corza Medical, S.L.U. 100%
- Corza Medical Sp. Z.o.o. 100%
- Corza Medical S.r.l. 100%
- Corza Medical BV 100%
- Surgical Specialties Germany GmbH 100%
- Corza Medical GmbH 100%
- Corza Medical GmbH 100%
- GTCR (Topaz) AcquisitionCo AS 100%
- Corza Medical, S.L.U., Sucursal em Portugal 100%
- Topaz Investment AS 100%
- Corza Medical Distribution GmbH Austria Branch 100%
- FSSB Chirurgische Nadeln GmbH 100%
- F&B GmbH 100%
- FSSB Chirurgische Nadeln GmbH Zweigniederlassung Pößneck 100%
Significant events
- “On 9 January 2024, the Company issued 100 ordinary shares with a nominal value of £0.01 each to Surgical Specialties UK Holdings Limited for a total consideration of £280,728,000, settled through the extinguishment of an amount owed to the group undertaking.”
- “On 26 March 2025, the Company entered into an additional loan with Corza Medical GmbH. This is a non-adjusting event, a loan of $18,858,700 (2023: $Nil) was granted to Corza Medical GmbH on 26 March 2025 with a maturity date of 16 July 2031.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ABAIR, Jason Christian | Director | 2025-03-31 | Sep 1973 | American |
| BURRIDGE, Rebecca Louise | Director | 2021-02-10 | Jun 1983 | British |
| CHAVES, Derek | Director | 2025-03-31 | Apr 1977 | American |
| LUCIER, Gregory Thomas | Director | 2025-03-31 | May 1964 | American |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BANKS, James Reginald | Secretary | 2003-06-02 | 2006-03-23 |
| BANKS, James Reginald | Secretary | 2002-03-07 | 2003-04-30 |
| DENT, Jay | Secretary | 2009-02-25 | 2014-07-29 |
| MOLINARO JR, Peter | Secretary | 2003-04-30 | 2003-06-02 |
| NESKE, Tammy | Secretary | 2013-10-08 | 2014-12-31 |
| PHINNEY, David | Secretary | 2006-03-23 | 2009-02-25 |
| PRENTICE, Hamish Murray | Secretary | 2000-01-04 | 2002-03-08 |
| SUTHERBY, Daniel Joseph | Secretary | 2014-12-31 | 2021-02-10 |
| NQH (CO SEC) LIMITED | Corporate Nominee Secretary | 1999-09-30 | 2000-01-04 |
| ADLOFF, Richard C | Director | 2004-11-22 | 2006-03-23 |
| BAILEY, Kenneth Thomas | Director | 2006-03-23 | 2013-10-08 |
| BANKS, Jame Reginald | Director | 2007-02-28 | 2007-09-24 |
| BANKS, James Reginald | Director | 2003-06-02 | 2006-03-23 |
| BARR, John | Director | 2014-12-31 | 2017-08-23 |
| BURMEISTER IV, Henry Augustus | Director | 2023-06-05 | 2024-07-30 |
| DAMICO, Joseph Francis | Director | 2003-04-30 | 2003-06-02 |
| DAU, Nathan Minh, Mr. | Director | 2020-11-27 | 2021-02-10 |
| DENT, Jay | Director | 2009-02-25 | 2014-07-29 |
| HUDSON, Michael Joseph | Director | 2004-11-22 | 2006-03-23 |
| HUDSON, Michael Joseph | Director | 2003-04-30 | 2003-06-02 |
| LYON, Douglas Lawson | Director | 2007-02-28 | 2007-09-24 |
| LYON, Douglas Lawson | Director | 2003-06-02 | 2006-03-23 |
| LYON, Douglas Lawson | Director | 2000-01-04 | 2003-04-30 |
| NESKE, Tammy | Director | 2013-10-08 | 2014-12-31 |
| PHINNEY, David | Director | 2006-03-23 | 2009-02-25 |
| PIETRAFESA II, Robert Edward | Director | 2000-05-05 | 2003-04-30 |
| PRENTICE, Hamish Murray | Director | 2000-01-04 | 2002-03-08 |
| SUTHERBY, Daniel Joseph | Director | 2017-03-10 | 2021-04-14 |
| TESTA, Thomas | Director | 2024-07-30 | 2024-12-31 |
| TESTA, Thomas Benjamin | Director | 2021-02-10 | 2023-06-05 |
| WANG, Lawrence Allen, Mr. | Director | 2019-04-16 | 2020-11-27 |
| WEST, Henry John | Director | 2003-04-30 | 2003-06-02 |
| NQH LIMITED | Corporate Nominee Director | 1999-09-30 | 2000-01-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Surgical Specialties Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 170 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-09-24 | AA | accounts | Accounts with accounts type full | |
| 2025-04-24 | AD03 | address | Move registers to sail company with new address | |
| 2025-04-24 | AD02 | address | Change sail address company with new address | |
| 2025-04-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-30 | RP04TM01 | officers | Second filing of director termination with name | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-09-11 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-08-06 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-12 | SH01 | capital | Capital allotment shares | |
| 2024-03-23 | DISS40 | gazette | Gazette filings brought up to date | |
| 2024-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-12 | GAZ1 | gazette | Gazette notice compulsory |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.